Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2
Melissa Baggieri, Silvia Gioacchini, Gigliola Borgonovo, Giorgia Catinella, Antonella Marchi, Pasquale Picone, Sonya Vasto, Raoul Fioravanti, Paola Bucci, Maedeh Kojouri, Roberto Giuseppetti, Emilio D’Ugo, F. Ubaldi, Sabrina Dallavalle, Domenico Nuzzo, Andrea Pinto, Fabio Magurano
Abstract
Natural products are a rich source of bioactive molecules that have potential pharmacotherapeutic applications. In this study, we focused on Artemisia annua (A. annua) and its enriched extracts which were biologically evaluated in vitro as virucidal, antiviral, and antioxidant agents, with a potential application against the COVID-19 infection. The crude extract showed virucidal, antiviral and antioxidant effects in concentrations that did not affect cell viability. Scopoletin, arteannuin B and artemisinic acid (single fractions isolated from A. annua) exerted a considerable virucidal and antiviral effect in vitro starting from a concentration of 50 µg/mL. Data from Surface Plasmon Resonance (SPR) showed that the inhibition of the viral infection was due to the interaction of these compounds with the 3CLpro and Spike proteins of SARS-CoV-2, suggesting that the main interaction of compounds may interfere with the viral pathways during the insertion and the replication process. The present study suggests that natural extract of A. annua and its components could have a key role as antioxidants and antiviral agents and support the fight against SARS-CoV-2 variants and other possible emerging Coronaviruses.